Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Deferred Taxes (2022 - 2024)

Bio Key International's Deferred Taxes history spans 3 years, with the latest figure at -$22998.0 for Q4 2024.

  • For Q4 2024, Deferred Taxes rose 79.83% year-over-year to -$22998.0; the TTM value through Dec 2024 reached -$144012.0, down 1.81%, while the annual FY2024 figure was -$22998.0, 82.84% up from the prior year.
  • Deferred Taxes for Q4 2024 was -$22998.0 at Bio Key International, up from -$114014.0 in the prior quarter.
  • Across five years, Deferred Taxes topped out at -$7000.0 in Q3 2023 and bottomed at -$114014.0 in Q4 2023.
  • The 3-year median for Deferred Taxes is -$21716.0 (2022), against an average of -$41111.5.
  • The largest annual shift saw Deferred Taxes crashed 457.96% in 2023 before it skyrocketed 79.83% in 2024.
  • A 3-year view of Deferred Taxes shows it stood at -$20434.0 in 2022, then plummeted by 457.96% to -$114014.0 in 2023, then soared by 79.83% to -$22998.0 in 2024.
  • Per Business Quant, the three most recent readings for BKYI's Deferred Taxes are -$22998.0 (Q4 2024), -$114014.0 (Q4 2023), and -$7000.0 (Q3 2023).